ImmunoACT
Company Details
Status: Private
Employees: 101-250
Location:
ImmunoACT, 1st Floor, R-977, T.T.C. Industrial Area, MIDC Rabale, Navi Mumbai, Maharashtra 400701, IN
Type:
sample
Technology:
sample
About: ImmunoACT, also known as ImmunoAdoptive Cell Therapy Private Limited, is an Indian biotechnology company specializing in cell and gene therapies. Founded by Dr. Rahul Purwar and Dr. Atharva Karulkar, the company aims to provide affordable access to innovative autologous Chimeric Antigen Receptor (CAR) T-cell therapies. It originated as a spin-off from the Indian Institute of Technology Bombay and is incubated at the Society for Innovation and Entrepreneurship.
The company focuses on translational research and development in cell and gene therapy. One of its notable products is NexCAR19, a cost-effective version of CAR-T therapy aimed at treating leukemia and lymphoma. ImmunoACT is committed to expanding its impact through partnerships, such as its collaboration with Caring Cross to commercialize TriCAR T-cell immunotherapy. The company strives to make advanced therapies more accessible to patients in India and beyond.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
ImmunoACT | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.